logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Pharmaceutical Intermediates > 2-[(4-m-ethoxy-3-methyl-pyridin-2-yl)methylsulfinyl]-5-pyrrol-1-yl-3H-benzoimidazole CAS 172152-36-2

2-[(4-m-ethoxy-3-methyl-pyridin-2-yl)methylsulfinyl]-5-pyrrol-1-yl-3H-benzoimidazole CAS 172152-36-2

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 172152-36-2

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15DAY

Payment Terms: L/C,D/P,T/T,D/A,Western Union,MoneyGram

Supply Ability: G,KG,TON

Get Best Price
Highlight:
Appearance::
Pale Grey To Light Grey Solid
CAS NO::
172152-36-2
Molecular Formula::
C19H18N4O2S
Molecular Weight::
366.43700
EINECS NO::
NA
MDL NO::
MFCD00942538
Appearance::
Pale Grey To Light Grey Solid
CAS NO::
172152-36-2
Molecular Formula::
C19H18N4O2S
Molecular Weight::
366.43700
EINECS NO::
NA
MDL NO::
MFCD00942538
2-[(4-m-ethoxy-3-methyl-pyridin-2-yl)methylsulfinyl]-5-pyrrol-1-yl-3H-benzoimidazole CAS 172152-36-2

Product Description:

Product Name:

2-[(4-m-ethoxy-3-methyl-pyridin-2-yl)methylsulfinyl]-5-pyrrol-1-yl-3H-benzoimidazoleCASNO: 172152-36-2


Synonyms:

Aldenon;

2-{[(4-m-ethoxy-3-methylpyridin-2-yl)methyl]sulfinyl}-6-(1h-pyrrol-1-yl)-1h-benzimidazole;

Ilaprazole [INN];


Chemical & Physical Properties:

Appearance: Pale grey to light grey solid

Assay :≥99.00%

Density: 1.39g/cm3

Boiling Point: 651℃ at 760 mmHg

Flash Point: 347.5℃

Refractive Index: 1.71

Vapor Pressure: 7.87E-17mmHg at 25℃

Storage: -20℃ Freezer

Solubility: Dichloromethane (Slightly), DMSO (Slightly), Methanol (Slightly)


Ilaprazole (trade name Noltec) is a proton pump inhibitor (PPI) used in the treatment of dyspepsia, peptic ulcer disease (PUD), gastroesophageal reflux disease (GORD/GERD) and duodenal ulcer. It is available in strengths of 5, 10, and 20mg.

Clinical studies show that ilaprazole is at least as potent a PPI as omeprazole when taken in equivalent doses. Studies also showed that ilaprazole significantly prevented the development of reflux oesophagitis.

Ilaprazole is developed by Il-Yang Pharmaceutical (Korea), and is still under clinical trials with US FDA. It has launched in Korea and China for the treatment of gastric ulcer, duodenal ulcer, gastroesophageal reflux disease and erosive esophagitis.


If you are interested in our products or have any questions, please feel free to contact us!


Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.